FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024000893> ?p ?o ?g. }

• W2024000893 endingPage "66" @default.
• W2024000893 startingPage "66" @default.
• W2024000893 abstract "Brief Reports1 January 1990Resolution of Musculoskeletal Symptoms in the Carcinoid Syndrome after Treatment with the Somatostatin Analog OctreotideSidney Smith, MD, Lowell Anthony, MD, L. Jackson Roberts, MD, John A. Oates, MD, Theodore Pincus, MDSidney Smith, MDSearch for more papers by this author, Lowell Anthony, MDSearch for more papers by this author, L. Jackson Roberts, MDSearch for more papers by this author, John A. Oates, MDSearch for more papers by this author, Theodore Pincus, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-112-1-66 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptCarcinoid tumors are neoplasms of the enterochromaffin cells, the primary clinical manifestations of which include flushing, diarrhea, cardiac valvular lesions, and carcinoid crises with bronchospasm and hypotension (1). The acute symptoms are inhibited by the long-acting octapeptide analog of somatostatin, octreotide (SMS-201-995) (2). Musculoskeletal symptoms have been reported (3) in patients with the carcinoid syndrome, although this problem has not been widely recognized. We describe three patients with the carcinoid syndrome in whom treatment with octreotide was followed by resolution of their musculoskeletal symptoms.Patient 1A white woman born in 1920 had metastatic carcinoid tumor noted as an incidental...References1. Oates J. The carcinoid syndrome [Editorial]. N Engl J Med. 1986;315:702-4. CrossrefMedlineGoogle Scholar2. KvolsMoertelO'ConnellSchuttRubinHahn LCMAJR. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med. 1986;315:663-6. CrossrefMedlineGoogle Scholar3. PlonkFeldman JJ. Carcinoid arthropathy. Arch Intern Med. 1974;134:651-4. CrossrefMedlineGoogle Scholar4. PeltonGulyaHrubyDuckiesYamamura JKVSH. Conformationally restricted analogs of somatostatin with high mu-opiate receptor specificity. Proc Natl Acad Sci USA. 1985;82:236-9. CrossrefMedlineGoogle Scholar5. BarnardGranthamLambertonO'DorisioJackson LWPTI. Treatment of resistant acromegaly with long-acting somatostatin analogue (SMS 201-995). Ann Intern Med. 1986;105:856-61. LinkGoogle Scholar6. Matucci-Cerinic M. Response of hypertrophic osteoarthropathy to drugs inhibiting growth hormone [Letter]. J Rheumatol. 1984;11:865-6. MedlineGoogle Scholar7. Matucci-CerinicLottiCappugiBoddiFattoriniPanconesi MTPVLE. Somatostatin treatment of psoriatic arthritis. Int J Dermatol. 1988;27:56-8. CrossrefMedlineGoogle Scholar8. DenkoGabriel CP. Effects of peptide hormones in urate crystal inflammation. J Rheumatol. 1985;12:971-5. MedlineGoogle Scholar9. LygrenOstensenBurholHusby IMPG. Gastrointestinal peptides in serum and synovial fluid from patients with inflammatory joint disease. Ann Rheum Dis. 1986;45:637-40. CrossrefMedlineGoogle Scholar10. Smythe H. Fibrositis and other diffuse musculoskeletal disease. In: Kelly WN, Harris ED Jr, Ruddy S, Sledge CB, eds. Textbook of Rheumatology. Philadelphia: W.B. Saunders; 1985:481-9. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: From Vanderbilt University School of Medicine and the Veterans Affairs Hospital, Nashville, Tennessee. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByA Case of Multicentric Carcinoid in a Patient with Psoriatic SpondyloarthropathySomatostatin and somatostatin receptors: implications for neoplastic growth and cancer biologyParaneoplastic neurological syndromes in patients with carcinoidThe clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?Paraneoplastic syndromes of the spinal cord, nerve, and muscleOctreotide Dependency and Headache: A Case ReportOctreotide in the Treatment of Disorders of the Gastrointestinal SystemAnalgesic effect of octreotide in headache associated with acromegaly is not mediated by opioid mechanisms. Case reportSomatostatin and octreotide in gastroenterologyMiscellaneous hormonesTreatment of the Eosinophilia–Myalgia SyndromeEosinophilia-myalgia syndrome due to l-tryptophan ingestion: report of four cases and review of the Maryland experience 1 January 1990Volume 112, Issue 1Page: 66-68KeywordsCarcinoid tumorEnterochromaffinHospital medicineHypotensionImmunologyLesionsMuscular dystrophiesResearch grantsRheumatologySomatostatin Issue Published: 1 January 1990 PDF DownloadLoading ..." @default.
• W2024000893 created "2016-06-24" @default.
• W2024000893 creator A5018107754 @default.
• W2024000893 creator A5046869165 @default.
• W2024000893 creator A5064101830 @default.
• W2024000893 creator A5069819965 @default.
• W2024000893 creator A5080101763 @default.
• W2024000893 date "1990-01-01" @default.
• W2024000893 modified "2023-10-18" @default.
• W2024000893 title "Resolution of Musculoskeletal Symptoms in the Carcinoid Syndrome after Treatment with the Somatostatin Analog Octreotide" @default.
• W2024000893 cites W2079983266 @default.
• W2024000893 cites W2116541892 @default.
• W2024000893 cites W2137709055 @default.
• W2024000893 cites W2337135362 @default.
• W2024000893 cites W2418569332 @default.
• W2024000893 doi "https://doi.org/10.7326/0003-4819-112-1-66" @default.
• W2024000893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2293820" @default.
• W2024000893 hasPublicationYear "1990" @default.
• W2024000893 type Work @default.
• W2024000893 sameAs 2024000893 @default.
• W2024000893 citedByCount "15" @default.
• W2024000893 countsByYear W20240008932015 @default.
• W2024000893 crossrefType "journal-article" @default.
• W2024000893 hasAuthorship W2024000893A5018107754 @default.
• W2024000893 hasAuthorship W2024000893A5046869165 @default.
• W2024000893 hasAuthorship W2024000893A5064101830 @default.
• W2024000893 hasAuthorship W2024000893A5069819965 @default.
• W2024000893 hasAuthorship W2024000893A5080101763 @default.
• W2024000893 hasConcept C126322002 @default.
• W2024000893 hasConcept C204232928 @default.
• W2024000893 hasConcept C2776297358 @default.
• W2024000893 hasConcept C2776365762 @default.
• W2024000893 hasConcept C2777513400 @default.
• W2024000893 hasConcept C2781025020 @default.
• W2024000893 hasConcept C2781151469 @default.
• W2024000893 hasConcept C2908862229 @default.
• W2024000893 hasConcept C71924100 @default.
• W2024000893 hasConcept C77231918 @default.
• W2024000893 hasConcept C90924648 @default.
• W2024000893 hasConceptScore W2024000893C126322002 @default.
• W2024000893 hasConceptScore W2024000893C204232928 @default.
• W2024000893 hasConceptScore W2024000893C2776297358 @default.
• W2024000893 hasConceptScore W2024000893C2776365762 @default.
• W2024000893 hasConceptScore W2024000893C2777513400 @default.
• W2024000893 hasConceptScore W2024000893C2781025020 @default.
• W2024000893 hasConceptScore W2024000893C2781151469 @default.
• W2024000893 hasConceptScore W2024000893C2908862229 @default.
• W2024000893 hasConceptScore W2024000893C71924100 @default.
• W2024000893 hasConceptScore W2024000893C77231918 @default.
• W2024000893 hasConceptScore W2024000893C90924648 @default.
• W2024000893 hasIssue "1" @default.
• W2024000893 hasLocation W20240008931 @default.
• W2024000893 hasLocation W20240008932 @default.
• W2024000893 hasOpenAccess W2024000893 @default.
• W2024000893 hasPrimaryLocation W20240008931 @default.
• W2024000893 hasRelatedWork W105130885 @default.
• W2024000893 hasRelatedWork W1480336872 @default.
• W2024000893 hasRelatedWork W1598883880 @default.
• W2024000893 hasRelatedWork W1986565282 @default.
• W2024000893 hasRelatedWork W2056215236 @default.
• W2024000893 hasRelatedWork W2062096358 @default.
• W2024000893 hasRelatedWork W2064683160 @default.
• W2024000893 hasRelatedWork W2125244608 @default.
• W2024000893 hasRelatedWork W2404099963 @default.
• W2024000893 hasRelatedWork W2519932268 @default.
• W2024000893 hasVolume "112" @default.
• W2024000893 isParatext "false" @default.
• W2024000893 isRetracted "false" @default.
• W2024000893 magId "2024000893" @default.
• W2024000893 workType "article" @default.